Login to Your Account

Gilead's Combination HIV Drug, Truvada, Wins FDA Clearance

By Kim Coghill

Wednesday, August 4, 2004
The FDA granted accelerated approval for Truvada, a fixed-dose combination of Gilead Sciences Inc.'s anti-HIV medications Emtriva and Viread. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription